Rafael Bejar, Senior VP, Chief Medical Officer at Aptose Biosciences Inc. (APTO), bought 10,000 shares at $2.56 ($26K) on 2021-11-19, disclosed to the SEC on 2021-11-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.